Newly activated UI Cancer Center clinical trials

The following study has recently been activated for patient enrollment by The University of Illinois Cancer Center Clinical Trials Office (CTO).

Click on the link to learn about the details regarding the study on For more information or questions about a study, email or call 312-355-5112.

A021806: A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Sponsor: Alliance for Clinical Trials in Oncology
Collaborator: National Cancer Institute
Principal Investigator: Yolande Chen, MD

Translate »